Comparative Clinical Study to Evaluate the Efficacy and Safety of Oral Liposomal Iron, Oral Iron Supported Lactoferrin and IV Iron Dextran in Children With Chronic Kidney Disease

NCT05714176 Phase 4 UNKNOWN

This is a randomized, parallel study that will be conducted on pediatric patients with CKD.

Details

Lead sponsor	Menoufia University
Phase	Phase 4
Status	UNKNOWN
Enrolment	90
Start date	2023-02-01
Completion	2024-12-31

Conditions

• CKD - Chronic Kidney Disease

Interventions

• Ferric Pyrophosphate Liposomal
• Lactoferrin
• Iron Dextran Injection

Primary outcomes

• Hemoglobin measure — 3 months
  Measure oxygen in blood by measuring hemoglobin by coloremetric assay